|
|
||||||||
|
FIGURE 6. 18F-DOPA coronal view after carbidopa pretreatment in patient with metastasized carcinoid, showing heterogeneity of receptor expression and metabolic activity. (A) 18F-DOPA PET showing high uptake in entire process. (B) Considerably heterogeneous 111In-octreotide uptake. Apparently, medial part of this tumor (arrows) had lost most of its somatostatin receptor expression while retaining metabolic activity and 18F-DOPA uptake.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |